Robert Sidbury, MD, MPH, chief, Division of Dermatology, Seattle Children's Hospital, speaks on the inflammatory mechanisms of atopic dermatitis and risk of comorbidities in affected patients. Can you ...
"Medical Journeys" is a set of clinical resources reviewed by physicians, meant for the medical team as well as the patients they serve. Each episode of this 12-part journey through a disease state ...
Jonathan Silverberg, MD, PhD, MPH, associate professor of dermatology, director of clinical research and patch testing, George Washington University School of Medicine and Health Sciences, discusses ...
Atopic dermatitis is an allergy affecting approximately 10% of the Japanese population, with symptoms closely related to social stress. In socially active adults, the disease often becomes chronic. In ...
Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window NEW YORK CITY -- ...
Mild-to-moderate Atopic Dermatitis (AD) may be adequately treated with a combination of trigger avoidance, moisturizers, topical corticosteroids, calcineurin inhibitors and/or crisaborole. However, ...
Minimal disease activity in atopic dermatitis is sustainable at one year in early responders. Discover predictors and ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results